SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

FDA Grants AstraZeneca Priority Review for Sonesitatug Vedotin

The FDA accepted AstraZeneca’s biologics license application for sonesitatug vedotin and granted Priority Review for second- and l

AZN

Related stories